Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 2
1980 1
1983 2
1987 1
1988 4
1989 3
1990 4
1991 3
1992 7
1993 6
1994 7
1995 5
1996 5
1997 6
1998 13
1999 7
2000 12
2001 5
2002 10
2003 13
2004 15
2005 18
2006 22
2007 14
2008 9
2009 14
2010 11
2011 8
2012 10
2013 12
2014 14
2015 10
2016 15
2017 11
2018 14
2019 8
2020 11
2021 9
2022 12
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Results by year

Filters applied: . Clear all
Page 1
Teprotumumab for Thyroid-Associated Ophthalmopathy.
Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS. Smith TJ, et al. Among authors: goldberg ra. N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949. N Engl J Med. 2017. PMID: 28467880 Free PMC article. Clinical Trial.
Pembrolizumab-Related Enophthalmos.
Manta A, Goldberg RA. Manta A, et al. Among authors: goldberg ra. Ophthalmology. 2020 Jan;127(1):121. doi: 10.1016/j.ophtha.2019.09.031. Ophthalmology. 2020. PMID: 31864472 No abstract available.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Oculocutaneous albinism.
Goldberg RA, Lally DR, Heier JS. Goldberg RA, et al. JAMA Ophthalmol. 2015 Mar;133(3):e143518. doi: 10.1001/jamaophthalmol.2014.3518. Epub 2015 Mar 12. JAMA Ophthalmol. 2015. PMID: 25763554 No abstract available.
Orbital steroid injections.
Goldberg RA. Goldberg RA. Br J Ophthalmol. 2004 Nov;88(11):1359-60. doi: 10.1136/bjo.2004.051755. Br J Ophthalmol. 2004. PMID: 15489472 Free PMC article. No abstract available.
Changing the face of thyroid eye disease.
Ugradar S, Goldberg RA, Douglas RS. Ugradar S, et al. Among authors: goldberg ra. Eye (Lond). 2023 Feb;37(2):197-199. doi: 10.1038/s41433-022-02186-0. Epub 2022 Jul 26. Eye (Lond). 2023. PMID: 35882983 Free PMC article. No abstract available.
Elegant diagnosis.
Goldberg RA. Goldberg RA. Arch Ophthalmol. 2005 Dec;123(12):1739-40. doi: 10.1001/archopht.123.12.1739. Arch Ophthalmol. 2005. PMID: 16344448 No abstract available.
Eyebrow ptosis.
Green JP, Goldberg RA, Shorr N. Green JP, et al. Among authors: goldberg ra. Int Ophthalmol Clin. 1997 Summer;37(3):97-122. doi: 10.1097/00004397-199703730-00008. Int Ophthalmol Clin. 1997. PMID: 9279645 Review. No abstract available.
Lateral canthoplasty.
Shorr N, Goldberg RA, Eshaghian B, Cook T. Shorr N, et al. Among authors: goldberg ra. Ophthalmic Plast Reconstr Surg. 2003 Sep;19(5):345-52. doi: 10.1097/01.IOP.0000087069.83107.A4. Ophthalmic Plast Reconstr Surg. 2003. PMID: 14506418 Review. No abstract available.
355 results